Overview

Origins and Mission
The National Cord Blood Program (NCBP) was created to investigate cord blood as a possible solution to a critical public health need – finding appropriate hematopoietic (blood-forming) stems cells for patients unable to find a matching and available bone marrow donor. In response, our scientists pioneered the concept of a full-service, public bank of frozen, ready-to-use stem cell grafts, derived from cord blood donated by delivering mothers and available for use by any patient where and when they might need it.

Our Program was formally founded in 1992 with a grant from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH). In 1993, we provided the first donated cord blood units to ever be used in bone marrow transplants, which were performed on two pediatric patients.

The Program Today

We have grown to become the largest public cord blood bank in the world. To date, more than 100,000 mothers have donated their newborn’s cord blood to our program, and nearly 5,500 patients have been treated in 41 different countries with stem cells from our diverse inventory now totaling over 60,000 units.

We employ highly-trained personnel at every step of the cord blood collection, processing, testing, storage and distribution process. We operate from a state-of-the-art facility in Long Island City, NY, and in the labor and delivery areas of several major hospitals. As a result of our rigorous, highly-automated operating procedures, and the use of processing and storage techniques and equipment we helped design and develop with manufacturers, we are able to deliver a precisely consistent and reliable stem cell product used by leading transplant centers, in cell therapy studies and by R&D organizations around the world.

We Are Part of A Comprehensive Health and Scientific Organization
Our Program is part of the New York Blood Center (NYBC), a non-profit organization that for more than 50 years has been safeguarding the everyday health of more than 20 million residents in the greater New York City area through the provision of blood, blood products and transfusion services.

Through NYBC’s network of blood centers across the Midwest, Mid-Atlantic and Northeastern states, and through its scientific and clinical divisions – including the Lindsley F. Kimball Research Institute, Comprehensive Cell Solutions, the National Center for Blood Group Genomics and the National Cord Blood Program – NYBC serves nearly 600 hospitals and dozens of research organizations, academic institutions, and biomedical companies each year throughout the nation and around the world.